首页 正文

Dupilumab elicits a favorable response in type-2 inflammatory comorbidities of severe atopic dermatitis

{{output}}
Background: This case is the first report describing rapid, successful treatment of severe atopic dermatitis (AD) and comorbid type-2 inflammatory diseases in the same patient, with dupilumab treatment, with no side-effects. ... ...